Vela Rx review

Vela Rx is operated by TBF Supplements LLC, according to its June 1, 2026 terms. The company describes itself as a telehealth platform connecting patients with independent clinicians and compounding pharmacies, rather than the prescriber or dispensing pharmacy. Its contact page lists a Sheridan, Wyoming business address and weekday support hours.

The treatment pages describe clinical review, provider-directed dose changes, portal messaging and scheduled check-ins. Those are useful service commitments, but they do not identify the clinician or pharmacy that would handle your prescription. Ask for those names and state-specific eligibility before sharing payment details; our guide to checking a compounding pharmacy explains what to verify.

The rendered homepage advertises both semaglutide and tirzepatide injections from $149 a month. The same cards display $199 and $269 alongside those starting prices. The public cards do not establish whether $149 is introductory, limited to particular doses or conditional on a longer plan. We would not use it as a dependable ongoing monthly budget without written terms.

Vela says its flat-rate program includes compounded medication, provider access, delivery and check-ins, without consultation charges or dose-change surcharges. Its terms describe a bundled subscription charge every 30 days. Confirm the first charge, subsequent charges, medication quantity and any taxes before comparing it with calendar-month or four-week plans elsewhere.

Both treatment FAQs say memberships need 30 days’ notice before the next billing cycle. The terms instead describe turning off auto-refill at least 48 hours before monthly processing. Those are materially different deadlines; do not assume the shorter one protects you from another charge. Ask support which rule governs the specific plan and retain its answer.

The terms separately discuss a 24-hour prescription-order cancellation window and say dispensed or delivered medication is not refundable. They list exceptions for issues such as a declined prescription, an unshipped order, a wrong item or damaged product. Ending a subscription and reversing an already processed medication order are different requests.

The program pages describe direct messaging with a provider, structured follow-ups, dose adjustments and temperature-controlled delivery in unmarked packaging. The contact page publishes support hours Monday through Friday, 9 a.m. to 5 p.m.; it does not establish round-the-clock clinical response times.

Before transferring care, confirm when the first review happens, who handles side effects between scheduled visits, and what to do if a shipment is delayed. A promise of discreet delivery is not a guaranteed arrival date or proof that your next dose will arrive before the current supply runs out.

The treatment pages use nationwide language, but their FAQs qualify service to states where Vela can serve patients. The pages reviewed did not provide a complete treatment-specific state list or name the dispensing pharmacy. A nationwide headline therefore does not confirm availability for your address.

Vela identifies its medication as compounded and includes a non-FDA-approval disclosure. Its trial-based weight-loss graphics and patient testimonials are not trials of Vela’s own compounded preparations. Ask why a compounded prescription is appropriate for your individual needs; do not treat these products as approved generic versions of branded drugs.

Vela may interest readers looking for provider messaging and a bundled injection program. The practical obstacle is not the number of features on the page; it is whether the low advertised price and cancellation rules are clear enough to budget around.

Get a written recurring quote, the applicable cancellation cutoff, the prescriber and pharmacy names, and your state’s availability. Until those details agree, the public offer is less predictable than the flat-rate language suggests.